µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º GZt] 38V)g
tK
H!xit
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Y5CE#&
||HIp9(3
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) pAuwSn#i
mg(56)
1. ICAM-1 kDh(~nfj
W
|e>
2. interleukin 12(IL-12) 8|GpfW3p2
gi>_>zStv
3. tumor infiltrating lymphocyte $H} Mn"G
?g4|EV-56
4. TCR/CD3 complex 9(WC#-,
`qz5rPyZ
5. hematopoietin receptor family GcCs}
(eo
Nk4_!
6. individual idiotype(IdI)
!ei20@
C>dJ:.K%H
7. integrin AHY)#|/)
8-ssiiJ}gh
8. colony-stimulatory factor (CSF) qEr[fC@x
MA#!<b('
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Y{|yB
`kSCH; mwP
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? J)|K/W9
OZm[iH
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ .G~5F- 8'
TcmZ0L^O
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ4$GRCq5N;
)ZyuF(C&
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ ]mo<qWRc>p
n12c075
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) FXEfD"
g4SYG)'R+
1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ {59VS
Nl
L9?/ -@M
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) Rn_W|"
ff./DMDafI
3. immunoglobulin superfamily (IgSF) h]DECd{
D4 ]B>
4. selectin FDs^S)B
$RNUr
\9A
5. anti-idiotypic antibody (¦ÁId) UMi`u6#
)u )$ `a
6. major histocompatibility complex(MHC) v[DbhIXU
qq7X",s
7. immunotolerance 4|41^B5Y
bKMR7&e.Ep
8. biological reponse modifier(BRM) _ u|FJTk
mS~ ]I$
9. immune reponse gene (Ir gene) u#@{%kPW
[gns8F#H\
10. reshaped antibody (or reconstituted antibody) $#ju?B~
V]kGcS}
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ,ibPSN5Ca
xgT~b9
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ ;!JX-J q
oBNX8%5w
2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? fxoi<!|iGY
@-&(
TRbZo
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ hN_f h J
Q6!v3P/h
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? M |({
4C
g?[&0r1
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ @6
;oN
r -q3+c^+
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? Ph#F<e(9
pba8=Z
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ Vl 19Md
4OOn, 09
¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ bH\C5zt6(
%`?;V;{=
1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? "rx^M*"
46K&$6eN
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ![@T iM
2\nN4WL
5.
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: 6mu<&m
@
6
tc:A5mK
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: 6hM]%
!0ce kSesr
̉񧄤 BeI;#m0
s
s`P QN
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ;Rhb@]X
#`La|a.-
1. CD8 zUs~V`0
}qiF^D}
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) L\ }Pzxn
U
!c]_q
3. immunoglobulin fold(Ig fold) Bf5
&}2u
BrJ
o!@<
4. cadherin (Ca-dependent cell adhesion moleculers) L`UG=7r q
P3iA(3I24<
5. idiotype-anti-idiotypic antibody immune network theory gEv-> pc
WY+(]Wkao
6. HLA class II antigen >[ ug
zJ
xfq]9<
7. complementarity-determining region (CDR) ch@x]@-;A3
,0!uem}1i
8. perforin(or pore-forming protein ,PFP) lDW!Fg
D@8jGcz62
9. high affinity IL-2 receptor 1GtOA3,~;-
F=XF]
10. artificial active immunization M@|w[ydQG
S|"Fgoj r
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ZCm1+Y$
ngP7'1I
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ*B0V<
mV
YgCc|W3{
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 o2DtCU-A
[#p&D~Du&
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£
jm[}M
Qi_&aU$>lM
4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ osl=[pm
D%-{q>F!gf
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ TfJL+a0
wG+=}1X
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? 1t+%Gv^sK
XdpF&B&K7Q
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ LZ{YmD&6]
"Nbos.a]5
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ Gz?2b#7v
J{d(1gSZ
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ K"L_`.&Q
>9=:sSQu
ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ
?w*yW;V`
&
1[y"S
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© m4@MxQm
3L>d!qD
1. immunoglobulin gene rearrangement 3YW=||;|Yg
, ;%y
f?
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) [EgW/\35
GB>aT-G7q
3. flow cytometry(FCM) lyyX
<=E{)
}p=g*Zo*C;
4. carrier effect X8b|]Nr
qgx?"$ Z
5. positive selection of T lymphocytes in thymus %hc'dZ
dAL3. %
6. mouse TH1(Th1) and TH2(Th2) subsets wz#A1F
b#/i.!:a
7. perforin (pore-forming protein ,PFP) \0ov[T N.>
A2NF<ZsD
8. ADCC(antibody-dependent cell-mediated cytotoxicity) JO=1ivZl
+{$QAjW(/
9. SH-2(src-homology region 2) ZY cd.? :6
', {7%G9
10. Ab2¦Â (internal image) pjwaL^
_6MdF<Xb/
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Gf0,RH+
rwSbqL^eM
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? g?G+dnl/8
$*\L4<(
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? >$H|:{D
>o~Z>lr
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ\:v$ZEDJ>
r&%.z*q
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ k1='c7s
Puh$%;x
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ!%PWig-
<G~>~L.E
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) a{'Z5ail
LA%bq_>f
ÃâÒßѧרҵ£º
AIRr{Y
.lN s4e
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ BqH]-'1G
qAY%nA>jO
2. ÊԱȽÏÈËT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? Jblj^n?Bm
3yA2WW
´«È¾²¡Ñ§×¨Òµ£º =IjQ4 0W
[/ M`
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦ÄÜ¿É·¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ hs+kr?Pg`
{9LWUCpsf
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØϵ¡£ IQH[Q9%
7~1IO|4t
Ïû»¯×¨Òµ£º o "z@&G" ^
57,dw-|xi
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ n_u1&a'
0N:XIGFa
2.¼òÊöճĤÏà¹ØÁÜ°ÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌص㡣·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? '%saL >0
n_nl{
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ Q.U$nph\%d
GV.A+u
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© w5=tlb
3)=c]@N0
1. Fas(CD95)/FasL @Xp~2@I=ls
``U^COD
2. common chain of cytokine receptor !g!5_|
E:`v+S_h
3 . TCR/CD3 complex Ro(Zmk\t
U_G gCI)
4. negaive selection of thymocytes KhbYr$
D L'iS
5. artificial active immune Ev"|FTI/
Z4hrn::
6. anti-idiotypic tCG76LH
<S75($
7. IgSF `Z"Q^
\b=Pj!^gwb
8. Integrin yS(}:'`r
}Ew hj>w
9. chemokine
gKz(=
zq+o+o>xo
10. B7/CD28 uj>WgU
(Rt7%{*
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© mrIh0B:`
7/7Z`
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ )a@k]#)Skm
W&(k!6<x
2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣 >_OYhgs1w
3>E%e!D%
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ O$/o'"@ /
o8
e?J\?
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£ oi}i\:
hI
7dsefNPb
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ ,p(<+6QZ
3rLTF\
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ s,#>m*Rh
ljl^ GFo
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© z[`@}}Q
;XM{o:1Y[
1. B7/CD28 `Al;vVMRO
AJ#Nenmj
2. Th1 subset CLvX!O(~
__mF?m
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© jw-0M1B
87hq{tTs]
4. antibody affinity maturation McB[|PmC
9tF9T\jW
5. AP-1 %|s+jeUDn|
>EY3/Go>
6. single chain variable fragment£¨ScFv£© p]3?gK-
Lemui)
7. NK cell receptor
pK0"%eA
&b:1I7Cp*
8. Zinkernagel-Doherty phenomenon t!RiU ZAo
SdD6 ~LS
9. Ig fold ):iA\A5q[
m *JaXa
10. CD40/CD40L eM8}X[
dAuJXGo
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© ` V##Y
9T<x&
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£ eA<0$Gs,h
#\
=F O>
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ !r<pmr3f@7
@;"|@!l|
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ 9H]{g*kL
YOcO4
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ 79;<_(Y
PUUwv_
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
'dn]rV0(C
kDsFR#w&`
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ #{;k{~;PF
+~p88;
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£ o2F)%T DY
{z{bY\
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© .6Pw|xu`Pw
,5h)x"s
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© DW[N|-L
rbWP78
1.Co-stimulators (or co-stimulating molecules) GB=X5<;
vQ
6^xvk]
2.NK-kB 4\iOeZR
f
;{N!Eb`S
3.Immunoglobulin superfamily U2W|:~K
M
C&(N
I
4.antigen-presenting cell (APC) .[ICx
.(cw>7e3D
5.death domain I=`U7
Bis"
)6Fok3u
6.CCR and CXCR _9F9W{'
&i6),{QN
7.Lectin (or mitogen) ?67Y-\}
)"7iJb<E
8.Clusters of differentiation, CD) UM"- nZ>[
inMA:x}cF1
9.B7 family 'a@/vx&J
k_rt&}e+Gi
10.Cytotoxic T lymphocyte, CTL) B|C2lu
Ng2twfSl$
11.IL-15 and IL-15 receptor (IL-15R) L>Fa^jq5
4V)kx[j
12.MHC restriction KJ)k =mJ
S%Uutj\/W
13.Affinity-chromatography vXrx{5gz
(c=6yV@
14.Cyctosprin A, CsA z]_wjYn Z
ZbW17@b
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) z!ZtzD]cb
/NI;P]s.
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Z&+ g;(g
On9A U:\
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 P~ >OS5^
#wwH m3
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ q 376m-+
O:;w3u7;u
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 -P$PAg5"2
NX*Q
F+
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© t&C1Oo}=3
] vHF~|/-
ÃâÒßѧרҵ£º P9^Xm6QO
24 ' J
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ xX&+WR
n,y ZRY
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ i#n0U/
U`(ee*}o
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ t%0VJB,Q2
{L{o]Ii?g
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) =7=]{Cx[
3wF;GG
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) LYTd
TP
Xx~Bp+
1. ADCC(antibody dependent cell-mediated cytotoxicity) I3L<[-ZE
gD@){Ip
2. »·æß¾úËØ(cyclosporin) {UI+$/v#
hE D}h![
3. KIR(killer cell inhibitory receptor) PO:{
t
03X1d-
4. HLDA(human leucocyte differentiation antigen) Naf0)3q>!
W:2( .?
5. Interleukin 18(IL-18) 9s
q
s2V:cMXFn
6. ÕûºÏËØ(integrin) K\Wkoi5
'o2Fa_|<#
7. Fas/FasL m+[Ux{$
zR:L!S
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) <)H9V-5aZ
'n3uu1C
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) Q(?#'<.#
oLeq!K}re
10. Th1/Th2 B~ GbF*j
N=}A Z{$
11. »ùÒòÒßÃç(DNAÒßÃç) X&`t{Id?6
G9cUD[GB
12. chemokines and chemokine receptor k="i;! Ge
KkbD W3-
13. ÃâÒßÄÍÊÜ ^jZbo{
FTUv IbT
14. ¹²´Ì¼¤·Ö×Ó yR{3!{r3(
+a+Om73B2
15. ËÀÍö½á¹¹Óò(death domain) dUZ
,m9u
zRr*7G
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) aX'*pK/-
Kw ]=
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? @#l=
l
}19\.z&J
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠon`3&0,.
m;QMQeGz
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î E ~<J
C"]
'5$b-x6 F
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ ukyZes8o K
x s|FE3:a
£¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå /a4{?? #e
M .mfw#*
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ EaN6^S=
Gyc]?m
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) yY q,*<G
!+v$)3u9
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ 0 @oJFJrO
4,DeHJjAlE
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ C~/a-
.?$gpM?i
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£